Status:
RECRUITING
European Registry for Transperineal Laser Ablation of Prostate (TPLA) for Lower Urinary Tract Symptoms
Lead Sponsor:
University of Florence
Conditions:
Benign Prostatic Hyperplasia
Prostatic Diseases
Eligibility:
MALE
18+ years
Brief Summary
The goal of this observational study is to assess mid- and long-term effectiveness of Transperineal Laser Ablation of Prostate (TPLA) for the treatment of lower urinary tract symptoms (LUTS) due to be...
Eligibility Criteria
Inclusion
- Age ≥18 years;
- Prostate volume ≥ 30 mL;
- Moderate-to-severe LUTS according to International Prostatic Symptoms Score (IPSS ≥8)
- Consent to participate;
Exclusion
- Absence of consent;
- Subsequent withdrawal of consent;
- Diagnosis or suspicion of prostate cancer at multiparametric magnetic resonance
- Documented bladder impaired contractility
- Urethral stenosis
- Previous prostate surgery
Key Trial Info
Start Date :
January 11 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2034
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT06564415
Start Date
January 11 2024
End Date
January 1 2034
Last Update
August 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AOU Careggi
Florence, Italy, 50134